These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 26001793

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease and Glanzmann thrombasthenia: a controlled, before and after trial.
    Eghbali A, Melikof L, Taherahmadi H, Bagheri B.
    Haemophilia; 2016 Sep; 22(5):e423-6. PubMed ID: 27478149
    [Abstract] [Full Text] [Related]

  • 23. Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia.
    Balci YI, Karabulut A, Kabukcu S, Sari I, Keskin A.
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):320-2. PubMed ID: 20460355
    [Abstract] [Full Text] [Related]

  • 24. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia.
    Franchini M, Lippi G.
    Expert Rev Hematol; 2014 Dec; 7(6):733-40. PubMed ID: 25387838
    [Abstract] [Full Text] [Related]

  • 25. Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry.
    Recht M, Rajpurkar M, Chitlur M, d'Oiron R, Zotz R, Di Minno G, Cooper DL, Poon MC.
    Am J Hematol; 2017 Jul; 92(7):646-652. PubMed ID: 28370369
    [Abstract] [Full Text] [Related]

  • 26. Low Concentrations of Recombinant Factor VIIa May Improve the Impaired Thrombin Generation of Glanzmann Thrombasthenia Patients.
    Levy-Mendelovich S, Levy T, Budnik I, Barg AA, Rosenberg N, Seligsohn U, Kenet G, Livnat T.
    Thromb Haemost; 2019 Jan; 119(1):117-127. PubMed ID: 30597506
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Use of rFVIIa in Preventing Recurrent Intra-articular Hemorrhages in a 15-Year-Old Patient With Glanzmann Thrombasthenia.
    Laguna P.
    J Pediatr Hematol Oncol; 2021 Nov 01; 43(8):e1120-e1123. PubMed ID: 33625096
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group.
    Poon MC, d'Oiron R.
    Blood Coagul Fibrinolysis; 2000 Apr 01; 11 Suppl 1():S55-68. PubMed ID: 10850567
    [Abstract] [Full Text] [Related]

  • 32. Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
    Tomita E, Takase H, Tajima K, Suematsu Y.
    Asian Cardiovasc Thorac Ann; 2017 Feb 01; 25(2):99-104. PubMed ID: 28114794
    [Abstract] [Full Text] [Related]

  • 33. Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia.
    Poon MC.
    Vasc Health Risk Manag; 2007 Feb 01; 3(5):655-64. PubMed ID: 18078017
    [Abstract] [Full Text] [Related]

  • 34. Perioperative management of Glanzmann's syndrome: how we did it!
    Depner C, Schmid R, Kirchhoff P, Oertli D.
    Blood Coagul Fibrinolysis; 2010 Apr 01; 21(3):283-4. PubMed ID: 20182353
    [Abstract] [Full Text] [Related]

  • 35. Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
    Di Minno G.
    Blood Rev; 2015 Jun 01; 29 Suppl 1():S26-33. PubMed ID: 26073366
    [Abstract] [Full Text] [Related]

  • 36. Acute Epidural Hematoma Following Acute Subdural Hematoma Evacuation in a Child With Glanzmann Thrombasthenia.
    Fernández-Castellano G, Mayorga-Buiza MJ, Gallego-Solano J, Vazquez-Rubio R, Rivero-Garvia M.
    J Neurosurg Anesthesiol; 2016 Oct 01; 28(4):431-3. PubMed ID: 26421897
    [No Abstract] [Full Text] [Related]

  • 37. The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery.
    Kale A, Bayhan G, Yalinkaya A, Yayla M.
    J Perinat Med; 2004 Oct 01; 32(5):456-8. PubMed ID: 15493726
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.